Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ: NTRA )

148.56 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17
Open 148.56
Bid (Size) 144.75 (3)
Ask (Size) 155.00 (1)
Prev. Close 148.56
Today's Range 148.56 - 148.56
52wk Range 87.20 - 183.00
Shares Outstanding 135,186,184
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
From Natera, Inc.
Via Business Wire
Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting
From Natera, Inc.
Via Business Wire

Performance

YTD
-7.50%
-7.50%
1 Month
-3.43%
-3.43%
3 Month
-13.59%
-13.59%
6 Month
+25.21%
+25.21%
1 Year
+63.18%
+63.18%

More News

Read More
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Turn Down
Via StockStory
How Do Investors Really Feel About Natera?
Via Benzinga
Deep Dive Into Natera Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
Via Benzinga
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Via Investor's Business Daily
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Assessing Natera: Insights From 10 Financial Analysts
Via Benzinga
3 Reasons NTRA Has Explosive Upside Potential
Via StockStory
Topics Government Stocks
Exposures Political US Equities
27.5% of Stanley Druckenmiller's $3.7 Billion Portfolio Is Invested in These 3 Under-the-Radar AI Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is the Market Bullish or Bearish on Natera?
Via Benzinga
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting
From Natera, Inc.
Via Business Wire
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
Via The Motley Fool
1 Mid-Cap Stock to Own for Decades and 2 to Brush Off
Via StockStory
Why Is Natera (NTRA) Stock Soaring Today
Via StockStory
Topics Stocks World Trade
Exposures Tariff US Equities
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
From Natera, Inc.
Via Business Wire
Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD
From Natera, Inc.
Via Business Wire
Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales
Via StockStory
Natera Reports Fourth Quarter and Full Year 2024 Financial Results
From Natera, Inc.
Via Business Wire
Natera (NTRA) Q4 Earnings: What To Expect
Via StockStory
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.